This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Maniadakis N, Pallis A, Fragoulakis V, Prezerakos P, Georgoulias V.Economic analysis of a multicentre, randomised, phase III trial comparing FOLFOXIRI with FOLFIRI in patients with metastatic colorectal cancer in Greece. Current Medical Research and Opinion 23: 2251-2257, No. 9, Sep 2007
Rights and permissions
About this article
Cite this article
FOLFIRI better value than FOLFOXIRI for metastatic CRC. Pharmacoecon. Outcomes News 538, 4 (2007). https://doi.org/10.2165/00151234-200705380-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705380-00009